Denali Therapeutics Inc
Officers & Directors
Jennifer Cook Director - February Vicki Sato Chairperson of the Board of Directors - February Jay Flatley Director - February Nancy A. Thornberry Director - February Ryan J. Watts, Ph.D. President, Chief Executive Officer, and Director (Principal Executive Officer) - February Steve E. Krognes Director - February Alexander O. Schuth, M.D. Chief Operating and Financial Officer (Principal Financial and Accounting Officer) - February Peter Klein Director - February David Schenkein Director - February Erik Harris Director - February Marc Tessier-Lavigne Director - February ,
Denali Therapeutics Inc currently has 503 employees.
News about Denali Therapeutics Inc Key Personnel |
Denali Therapeutics Sets Ambitious 2025 Milestones Despite Financial StrugglesDenali Therapeutics Inc. a biotech firm focused on developing therapies for neurodegeneration and lysosomal storage diseases, recently outlined its key anticipated milestones for 2025. The company’s Chief Executive Officer, Ryan Watts, Ph.D. is scheduled to present these goals at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. This presentation comes amid the backdrop of significant financial challenges, as Denali has reported a cumulative net loss of $366 million for the 12 months ending in the third quarter of 2024. This translates to a concerning negative return on investment (ROI) of -27.29%. In terms ...
|
|
